Xcout Intel
Fermelanta
Fermelanta, Inc. is a Japan-based biomanufacturing startup headquartered in Nonoichi, Ishikawa, that develops sustainable fermentation platforms utilizing microbes to replace petrochemical processes.
Subscribe to see Fermelanta’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Fermelanta at a glance
Fermelanta is a biotech / drug discovery company headquartered in Japan. Its most recent funding round, Series A, raised $13.8M in August 2025. Xcout tracks 1 named person at Fermelanta, including Shogo Fukizaki (co-founder and CEO).
Fermelanta leadership
- Shogo Fukizakico-founder and CEO
Fermelanta funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $13.8M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Fermelanta competitors
A few of Fermelanta's closest competitors — see the full list of competitors and alternatives →
Manus Bio Inc. uses industrial fermentation and bio-manufacturing technology to produce natural ingredients as alternatives to petroleum-derived and scarce products.
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
Amyris, Inc. is a vertically integrated biomanufacturing company that converts plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products using precision fermentation.
Anomaly Bio is a Singapore-based company founded in 2025 that develops next-generation biomanufacturing techniques through engineered microbes. The company focuses on innovative biomanufacturing solutions, expanding its R&D team and laboratory facilities in Singapore.
Saku Biosciences is an early-stage life sciences company founded in 2024 to improve the economics of biomanufacturing. The firm develops high-performance host cell products designed to advance biological manufacturing processes and therapeutic production. It operates out of Los Angeles, California, with a small team of approximately 8 employees.
Nature's Toolbox, Inc. (NTx) is a biotechnology company based in Rio Rancho, New Mexico, that advances the healthcare industry with cutting-edge biomanufacturing solutions, including proprietary platforms like NTxpress and NTxscribe.
Get Fermelanta's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Fermelanta? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Fermelanta in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access